We only have this paper's title and publication details.
Read it at the source"Teprotumumab and hearing loss: hear the warnings." Orbit, 40(4), pp. 355–356
No takes yet. Share an insight, caveat, or question.
Chern et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: